Search
Maravai LifeSciences Holdings Inc
MRVIAdd to Watchlist
6.840USD
-0.040-0.58%
Close 09-16 16:00（ET）
1.02BMarket Cap
LossP/E TTM
Maravai LifeSciences Holdings Inc (MRVI) Stock Price Target & Forecast
Analyst Rating
Based on 9 analysts giving stock ratings to Maravai LifeSciences Holdings Inc in the past month.
Buy
2 Strong Buy
3 Buy
4 Hold
0 Sell
0 Strong Sell
Target Price
7.417USD+7.80%
MRVI Analyst Recommendation Trends
In the current month, MRVI has received 3 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MRVI average Analyst price target in the last month is 7.417.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
4
4
5
6
6
6
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
9
10
11
11
11
11
11
MRVI Analyst Rating for Peer Comparison
Updated: Sep 16, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
argenx SE
ARGX
10
13
3
0
0
26
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Ascendis Pharma A/S
ASND
10
10
0
0
0
20
Financial Forecasting
Based on analysts' estimates, MRVI EPS is projected to reach -0.057 in FY2026Q3, following reported EPS of -0.084 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.07
-0.05
-0.04
-0.06
-0.05
Actual
-0.25
-0.03
-0.08
--
--
Surprise
-246.83%
+45.92%
-93.97%
--
--
FAQs
What is Maravai LifeSciences Holdings Inc's expected revenue for the next quarter?
Maravai LifeSciences Holdings Inc's expected revenue is 43.67M.
What is Maravai LifeSciences Holdings Inc's price target?
Analysts forecast that Maravai LifeSciences Holdings Inc's price target is USD 7.42, with the highest forecast at USD 8.00 and the lowest forecast at USD 6.50.
How have Maravai LifeSciences Holdings IncMRVI's recent earnings per share performed?
The market expectation was USD -0.08, while Maravai LifeSciences Holdings IncMRVI's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD -0.06.
What is the analyst rating for Maravai LifeSciences Holdings Inc?
Based on the ratings of Maravai LifeSciences Holdings Inc's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.